Palliative care and hematological malignancies: Increased referrals at a comprehensive cancer centre

Journal of Palliative Medicine

Volumn 16, Issue 5, 2013, Pages 537-541

  Corbett, Cathy Lynn ^a   Johnstone, Martina ^b   Trauer, James McCracken ^c   Spruyt, Odette ^b  

^a ALFRED HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DATA ANALYSIS; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LYMPHOMA; MEDICAL RECORD; MULTIPLE MYELOMA; MYELOPROLIFERATIVE DISORDER; OUTPATIENT; PALLIATIVE THERAPY; PATIENT REFERRAL; SYMPTOM;

EID: 84877871335     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0377     Document Type: Article

References (25)

1. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (eds): International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland: World Health Organisation, 2000
2. Swerdlow SHCE, LHarris N, Jaffe E, Pileri S, Stein H, Thiele J: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer, 2008
3. McGrath P: Qualitative findings on the experience of end-oflife care for haematological malignancies. Am J Hosp Palliat Care 2002;19:103-111
4. Hunt RW, Fazekas BS, Luke CG, Priest KR, Roder DM: The coverage of cancer patients by designated palliative services: A population-based study, South Australia, 1999. Palliat Med 2002;16:403-409
5. Bruera E, Russel N, Sweeney C, Fisch M, Palmer JL: Place of death and its predictors for local patients registered at a comprehensive cancer centre. J Clin Oncol 2002;8:2127-2133
6. Cheng WW, Willey J, Palmer JL, Zhang T, Bruera E: Interval between palliative care referral and death among patients treated at a comprehensive cancer centre. J Palliat Med 2005;8:1025-1032
7. Manitta VJ, Philip JA, Cole-Sinclair MF: Palliative care and the haemato-oncological patient: Can we live together? A review of the literature. J Palliat Med 2010;13:1021-1025
8. McGrath P, Holewa H: Special considerations for haematology patients in relation to end-of-life care: Australian findings. Euro J Cancer Care 2007;16:164-171
9. National Institute for Clinical Excellence: Improving Outcomes In Haematological Cancers: The Manual. London: National Institute for Clinical Excellence, 2003
10. Bruera E, Kuehn N, Miller MJ, Selmser P, MacMillan K: The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6-9
11. Maltoni M, Nanni O, Pirovano M, et al.: Successful validation of the palliative prognostic score in terminally ill cancer patients: Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1999;17:240-247
12. Nekolaichuk CL, Fainsinger RL, Lawlor PG: A validation study of a pain classification system for advanced cancer patients using content experts: The Edmonton Classification System for Cancer Pain. Palliat Med 2005;19:466-476
13. Palliative Care Outcomes Collaboration: Outcomes in Palliative Care; Peter MacCallum Report 11 January -June 2011. Canberra: Australian Government Department of Health and Ageing, 2011. Unpublished
14. Maddocks I, Bentley L, Sheedy J: Quality of life issues in patients dying from haematological malignancies. Ann Acad Med Singapore 1994;23:244-248
15. Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR: Haematological malignancy: Are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-Analysis of published data. Palliat Med 2011;25:630-641
16. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E: Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumours. J Palliat Med 2008;11:422-427
17. Bauduer F, Capdupuy C, RenouxM: Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases. Support Care Canc 2000;8:302-306
18. Temel JS, Greer JA, Muzikansky A, et al.: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-742
19. Fadul N, Elsayem A, Palmer JL, Zhang T, Braiteh F, Bruera E: Predictors of access to palliative care services among patients who died at a Comprehensive Centre. J Palliat Med 2007;10:1146-1152
20. Ansell P, Howell D, Garry A, et al.: What determines referral of UK patients with haematological malignancies to palliative care services? An exploratory study using hospital records. Palliat Med 2007;21:487-492
21. Osta BE, Palmer JL, Paraskevopoulos T, et al.: Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer centre. J Palliat Med 2008;11:51-57
22. Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A; Haematological Malignancy Research Network: The Haematological Malignancy Research Network: A new information strategy for population based epidemiology and health service research. Br J Haematol 2010;148:739-753
23. Auret K, Bulsara C, Joske D: Australasian haematologist referral patterns to palliative care: Lack of consensus on when and why. Intern Med J 2003;33:566-571
24. Boyce A, McHugh M, Lyon P: Proactive palliative care choices for haematology day unit patients. Int J Palliat Nurs 2003;9:544-550
25. Elsayem A, Smith ML, Parmley L, et al.: Impact of a palliative care service on in-hospital mortality in a comprehensive cancer centre. J Palliat Med 2006;9:894-902